Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516199 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Electronic (PDF)Add to Basket
Site LicenseAdd to Basket
Live Chat Live Help Software for Website

Biomarkers, Tests and Trends for Drug R&D

Takeda Pacific, Feb 2010, Pages: 144


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

This report is about the world market for biomarkers and tests used for drug R&D. The study reviews and analyzes the market by examining biomarker related drug R&D spending, trends, major diseases, applications, M&As, alliances, tools & technologies, products and R&D services. This report provides a detailed outlook of the market for biomarkers and related genomic, proteomic, or other tests used in drug R&D programs. The research report also touches on metabolomic and imaging biomarkers. This study sizes the world market and growth rate of biomarkers and tests for drug R&D spending to 2014.

The major drug makers face many daunting challenges that are being mitigated by the companies using key business and technical strategies that utilize biomarkers. Despite the recent severe recession, this business area is set for strong continued double-digit growth as biomarkers and tests in drug/therapeutic R&D enable emerging opportunities, potentially worth billions of dollars.

This business report updates our current view about biomarkers for drug R&D. The study discusses ongoing government initiatives that foster worldwide development in biomarkers and personalized medicine opportunities. Their expectation is to streamline commercializing new, safer, drugs and co-developed companion predictive tests by integrating biomarkers and pharmacogenomic (PGx) tests into the critical path of drug R&D. The study discusses how clinical trials are undergoing important emerging changes that integrate biomarkers and assays into the drug development process to provide more useful information in order for drug makers to make better product development decisions.

This study uses more than 51 figures and tables to illustrate its insightful findings. The report offers detailed information including data tables about key technologies, M&As, alliances and so on. More than thirty selected companies are profiled with details such as contact information, business overview, financial details and product information. This report uses hyperlinks to help readers jump to Table of Content items or to text-linked Internet sites.

This must-have report would benefit people with job titles including CEO, VPs, Director of Business Development, Research Directors, Entrepreneurs, Venture Capitalists, Investment Planners, Research Scientists, Consultants or Industry Analysts.


Product samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

Biomarkers and Tests for Pharma/ Biotech R&D – Companies Products and WW Market, 2006-2011

Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D -- Companies Products and WW Market, 2004-2009

Biomarkers - Technologies, Markets and Companies

Biochips and Microarrays - Technologies, Markets and Companies

Personalized Medicine: Companies, Trends and World Market

Cytogenetics - Technologies, Markets and Companies

Nanobiotechnology Applications, Markets and Companies

Proteomics - Technologies, Markets and Companies

Epigenetics: Tools, Diagnostics, Drugs and World Market

Animal Biotechnology - Technologies, Markets and Companies



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds